COVID-19 in a patient with neuroendocrine pancreatic cancer – Case Report

ABSTRACT

Coronavirus disease 2019 (COVID-19) has developed into a pandemic and caused thousands of deaths worldwide. SARS CoV-2 infection can have a significant impact on cancer diagnosis, prognosis, and therapeutic effects. Some studies show a worse trend among cancer COVID-19 patients. However, other studies also indicate that the percentages of SARS-CoV-2 infection and severe events in cancer patients are not higher compared to the general population. It may be complicated in cancer patients, a high-risk group for SARS CoV-2 infection. The case study describe SARS CoV-2 infection in a 71-year-old male patient with neuroendocrine pancreatic cancer, who presented relatively mild illness without the need for intensive care. Complete recovery was achieved without short-term sequelae, and systemic oncological therapy was discontinued.